October 30, 2026

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 59.92% Potential Upside

AngioDynamics, Inc. (ANGO), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, has been capturing attention with a notable potential..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a Potential 141% Upside in Biotech Innovations

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, with its focus on addressing cancer resistance mechanisms through innovative therapies. As a clinical-stage..

SIGA Technologies Inc. (SIGA)

⚠️ No article content returned.

..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unlocking a Potential 123.95% Upside with Cutting-Edge Biotech Innovations

Cullinan Therapeutics, Inc. (CGEM), a promising clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative therapies for autoimmune diseases and cancer. Headquartered..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Strong Buy Ratings Signal 49.93% Potential Upside

Amylyx Pharmaceuticals, Inc. (AMLX) is making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Cambridge, Massachusetts, this clinical-stage..

Abivax SA (ABVX) Stock Analysis: Exploring an 83.68% Potential Upside in the Biotechnology Sector

Investors with a keen interest in the healthcare sector might find Abivax SA (ABVX) an intriguing opportunity in the biotechnology industry. This French-based company, with a..

Standard BioTools Inc. (LAB) Stock Analysis: Evaluating a 117.74% Potential Upside in the Healthcare Sector

Standard BioTools Inc. (NASDAQ: LAB), operating in the healthcare sector with a focus on medical devices, presents an intriguing case for investors seeking substantial growth opportunities...

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Challenges with an Eye on Growth Potential

Fulgent Genetics, Inc. (NASDAQ: FLGT), a notable player in the healthcare sector, particularly in diagnostics and research, presents a multifaceted opportunity for investors. Based in El..

MBX Biosciences, Inc. (MBX): Analyst Consensus Reveals 75% Upside Potential Amid Strong Buy Ratings

MBX Biosciences, Inc. (MBX), a biopharmaceutical torchbearer in the healthcare sector, has captured the attention of investors with a promising outlook. Specializing in precision peptide therapies..

Inventiva S.A. (IVA) Stock Analysis: A Biotech with 307% Upside Potential and Strong Buy Ratings

Inventiva S.A. (IVA), a France-based clinical-stage biopharmaceutical company, is capturing attention in the investor community with its remarkable potential upside of over 307%. Specializing in the..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Growth Challenges with Innovative Solutions

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a name that resonates within the medical device sector, particularly for its pioneering approaches to bunion correction technology. With..

Nurix Therapeutics, Inc. (NRIX) Investor Outlook: Riding High on an 8,426% Revenue Growth Surge

Nurix Therapeutics, Inc. (NASDAQ: NRIX) stands out in the biotechnology sector with its impressive financial metrics and ambitious pipeline of innovative therapies. With a market capitalization..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a 77% Upside Potential in the Biotechnology Sector

Verastem, Inc. (NASDAQ: VSTM) presents a compelling opportunity for investors in the biotechnology sector, driven by its innovative approach to cancer treatment and a remarkable potential..

Orthofix Medical Inc. (OFIX) Stock Analysis: Potential Upside of 26.95% Captures Investor Attention

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the medical devices sector specializing in spine and limb reconstruction technologies, has recently captured investor attention with..

COMPASS Pathways (CMPS): Analyst Consensus Points to a 94% Upside, Is It Time to Invest?

Investors with an eye on the healthcare sector, particularly in the burgeoning field of mental health treatment, may find COMPASS Pathways Plc (NASDAQ: CMPS) a compelling..

GH Research PLC (GHRS) Stock Analysis: Biotech Innovator with Nearly 100% Upside Potential

GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, is capturing the attention of investors with its ambitious therapeutic innovations and impressive analyst..

Enliven Therapeutics, Inc. (ELVN) Investor Outlook: A Promising 65% Upside Potential in the Biotech Sector

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors with its impressive potential upside, standing at 65.08%. This Boulder, Colorado-based biotechnology company is a..

Claritev Corporation (CTEV) Stock Analysis: Eyeing a Potential 91.67% Upside with Strategic Healthcare Solutions

For investors navigating the healthcare sector, Claritev Corporation (CTEV) presents a compelling opportunity, especially with an impressive potential upside of 91.67%. As a key player in..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator With a 123% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a dynamic player in the biotechnology sector, is capturing investor attention with a robust potential upside of 123.25%. Specializing in the development..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A 76% Upside Potential in the Biotech Sector

Stoke Therapeutics, Inc. (NASDAQ: STOK), a promising player in the biotechnology sector, is drawing significant attention from investors due to its pioneering approach to treating severe..

Search

Funds

October 30, 2026

Search

Funds

October 30, 2026

FTSE 100

Funds